Biocartis – Idylla for Colorectal Cancer
Biocartis Idylla™ for colorectal cancer
The Idylla solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
19Mar
13Mar
Asuragen – AmplideX Nanopore Carrier Plus
Introducing the Asuragen AmplideX® Nanopore Carrier Plus Kit* – a revolutionary solution for carrier screening for challenging hard-to-read genes, leveraging long-read sequencing technology to provide unparalleled insights into genetic conditions. Expanded prenatal screening protocols traditionally require multiple methods to ensure full coverage of genes of interest.
13Mar
Devyser NIPT RHD
Benefit from proven, highly sensitive technology to conduct accurate non-invasive screening for fetal RHD that helps clinicians avoid untargeted and unnecessary treatment.
03Jan
Why does stabilisation matter?
By stabilising blood samples, clinicians and laboratories can ensure that the data collected during liquid biopsy is an accurate reflection of what is in the patient’s blood.
11Oct
Invivoscribe Controls Portfolio Catalogue 2024
Discover the Invivoscribe control portfolio
Invivoscribe offers an extensive range of General Purpose Reagents (GPRs) and Research Use Only (RUO) controls.
08Oct
Think Biocartis Idylla
WHEN TIME MATTERS. THINK BIOCARTIS IDYLLA*. YOUR BIOMARKER TEST RESULTS WITHIN 3 HOURS.
The Idylla™ solution is a revolutionary, fully automated, real-time PCR based molecular testing system designed to offer results in a minimum amount of time.
18Sep
ZytoVision – Now IDVR Certified
Abacus dx are thrilled to announce ZytoVision* received their In Vitro Diagnostics Regulation (IVDR) certification for its selected product portfolio.
25Jun
Asuragen – QuantideX BCR-ABL
Asuragen’s Precision Oncology Solutions.
Revolutionising Precision Oncology with QuantideX®: Where Sensitivity Meets Scalability
28May
Invivoscribe NPM1 MRD Assay
Just launched! NPM1 MRD Assay* by Invivoscribe.